This study investigates the safety and immune response to an investigational vaccine designed to prevent lower respiratory tract disease caused by human metapneumovirus (hMPV) and respiratory syncytial virus (RSV) in adults aged 60 years and older. The study aims to understand how well the vaccine works in creating an immune …
